9th ISMERAD | Alpha Therapy: New approaches in radionuclide therapy – April 26, 2024
Published on: March 21, 2024
The 9th Symposium on Medical Radioisotopes is set to be a pivotal event, offering a comprehensive overview of the current state and future outlook of medical radioisotopes. The symposium aims to provide attendees with invaluable insights into various aspects of this dynamic field.
The event’s objectives are ambitious yet crucial. It seeks to inform participants about the global production prospects of medical radioisotopes in the forthcoming years, emphasizing the importance of addressing challenges in transportation and distribution, including safety, security, transparency, and prompt delivery. Additionally, the symposium endeavors to showcase groundbreaking advancements in radiopharmacy and nuclear medicine, while also introducing new industrial and research initiatives poised to shape the field’s trajectory.
Key highlights of the symposium include an opening talk by Zéna Wimana from HUBruxelles, who will shed light on Lu-177 and its potential in therapy, setting the stage for further discussions. Subsequent sessions will cover a range of topics, including the origin and production challenges of alpha-emitters, logistical concerns such as waste management and transportation, clinical potential and dosimetry studies, and glimpses into the future of medical radioisotopes.
The lineup of esteemed speakers includes experts like Sven Van den Berghe, Matthijs Sevenois, Philippe Dasse, Filip De Vos, Pascal Froment, Hans Van De Maele, Mike Sathekge, Michel Koole, Florian Rosar, and Thierry Stora, each bringing their unique perspectives and insights to the table.
As anticipation mounts for this significant event, attendees can expect to gain invaluable knowledge, foster meaningful connections, and contribute to shaping the future landscape of medical radioisotopes.
The Symposium is intended for:
- Researchers and professionals active in the subfields of interest;
- European and Belgian health authorities and regulators;
- Radioisotope distributors and related transport companies
Général
The 9th Symposium on Medical Radioisotopes intends to:
- Provide information on the perspectives of the world production of medical radioisotopes during the years to come;
- Discuss challenges of the transport and distribution processes including safety, security, transparency and prompt delivery;
- Present breakthroughs in radiopharmacy and nuclear medicine;
- Introduce new industrial and research initiatives.
Sujets
- Session 1: Origin/production of alpha-emitters. Challenges for the future – Overview of the activities
- Session 2: Logistics (waste management)
- Session 3: Studies | Clinical Potential | Dosimetry
- Session 4: The future
Programme
09:00 Registration and welcome coffee
09:30 Opening
- Welcome: Hans Van De Maele, PC Secretary
- Introduction: Bernard Ponsard, PC Chair
- Formal Opening: Ignace Lemahieu, RUG
09:45 Opening talk
- Lu-177 and the perspective of alpha therapy | Zéna Wimana, HUBruxelles
Session 1: Origin/production of alpha-emitters. Challenges for the future – Overview of the activities
- Ac-225 | Sven Van den Berghe, PanTera
- At-211 | Matthijs Sevenois, Molecular Imaging & THerapy research group (MITH)
- Pb-212 | Philippe Dasse, ARTBIO
11:00 Coffee break and poster session
11:30 Session 2: Logistics (waste management)
- Centralized radiopharmacies | Filip De Vos, Ghent University, Department of Radiopharmacy
- Waste Management | Pascal Froment, Be.Sure
- Drone Logistics – AEGLE project on drone logistics for radiopharmaceuticals | Hans Van De Maele, ORI Consult – AEGLE Drone Services
12:30 Poster session
- Poster competition
13:00 Lunch
14:00 Plenary talk
- Activities of HERCA in the frame of medical waste mgmt & logistics – European harmonization | TBC
Session 3: Studies / Clinical Potential / Dosimetry
- NTP – Clinical Potential | Mike Sathekge, University of Pretoria
- Challenges in Dosimetry | Michel Koole,KUL
15:30 Coffee break and poster session
16:00 Session 4: The future
- Potential of Terbium-161 | Florian Rosar, Nuclear Medicine Physician, Department of Nuclear Medicine, Saarland University
- PRISMAP: projects/preclinical studies REX on projects | Thierry Stora, CERN
16:45 Poster prize ceremony
- Traditionally 3 prizes are given for the best posters, respectively 500, 350 and 150 €
17:00 Closing
- Eric van Walle
17:05 Reception
Organisation
ISMERAD vzw
Préparation
Call for posters to the researchers in the field
Please submit the abstract(s) (20 to 30 lines, title and authors not included) for peer-review by mail to
bernard.ponsard@sckcen.be & h.vandemaele@be-wis.com
Indicate clearly who is the principal investigator.
Deadline: March 31, 2024.
The abstracts of the accepted posters will be published. Similarly to the previous editions, this time too, three prizes (respectively 500, 350 and 150 €) will be allotted for the best three posters.
Prix
€200 – regular parcipants
€ 30 – students